Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Phytochem Remedies IPO
Price Band
₹
Issue Size
₹38.22 Cr
Lot Size
1,200 shares
Min Investment
₹235,200
2 LOTS MIN
GMP
—
Issue Price
₹98.0
Phytochem Remedies IPO AI Summary
- Phytochem Remedies IPO is listed on BSE SME in the Other Consumer Services sector.
- Subscription window: 18 Dec–22 Dec 2025, listing on 26 Dec 2025.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Phytochem Remedies IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 22 Dec 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Overall Subscription
0.57x
| Category | Subscription | Status |
|---|---|---|
| NII (HNI) |
0.31x
|
0.31x |
| Retail (RII) |
0.83x
|
0.83x |
| Total | 0.57x | 0.57x |
Auto-updated every 5 min · As of 22nd Dec 2025 18:21
Phytochem Remedies IPO Grey Market Premium (GMP) Today
GMP not available yet
Grey Market Premium is updated daily. Check back closer to the listing date.
About the Company
Incorporated in 2002, Phytochem Remedies (India) Limited is a manufacturer of corrugated boxes and corrugated board solutions, catering primarily to industries such as food & beverages, FMCG, pesticides, pharmaceuticals, and automotive, based in Jammu, India. The company operate in two units at Bari Brahmana, Jammu, with Unit 1 having a total allocated area of 43,360 Sq. Ft. and Unit 2 having an allocated area of 1,73,440 Sq. Ft. Currently, Unit 1 is utilizing approximately 12,000 Sq. Ft. and Unit 2 is utilizing approximately 55,000 Sq. Ft. of total area of respective units. Products: Corrugated Boxes (3- Ply, 5-Ply, & 7-Ply) Printed Corrugated Boxes Corrugated Rolls Corrugated Pads and Sheets As on date September 30, 2025, the company had 51 employees. Competitive Strengths: Long-standing relationships with a stable customer base Track record of consistent financial performance and growth Well established manufacturing facility with a focus on sustainability and readiness for expansion and technology advancement Well-diversified product portfolio with wide industry applications
Company Financials (₹ Cr)
As of 2025-09-30
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 53.68 | 44.50 | 41.85 | 37.07 |
| Total Income | 25.01 | 36.81 | 32.90 | 20.83 |
| Profit After Tax | 3.75 | 4.48 | 2.31 | 0.82 |
| EBITDA | 6.72 | 8.69 | 5.88 | 2.91 |
| NET Worth | 16.89 | 13.14 | 8.74 | 6.42 |
| Reserves and Surplus | 9.02 | 9.99 | 5.51 | 3.20 |
| Total Borrowing | 19.32 | 18.69 | 21.02 | 20.30 |
Key Ratios
EPS
₹5.68
NAV
₹41.71
ROE
34.07%
ROCE
25.29%
RoNW
34.07%
P/B Value
2.35
P/E Ratio
17.24
Market Cap
₹115.39 Cr
PAT Margin
12.25%
Debt/Equity
1.42
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| G. K. P. Printing & Packaging Ltd | 10.18 | 3.8% | 18.36 | 0.39 | 0.39 |
| Worth Peripherals Limited | 110.28 | 9.1% | 14.43 | 10.03 | 10.03 |
| Perfectpac Ltd | 56.36 | 8.4% | 20.49 | 4.73 | 4.73 |
| Phytochem Remedies (India) This IPO | 41.71 | 34.07% | — | 14.21 | 14.21 |
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding capital expenditure requirements for the purchase of equipment/machineries 13.60 2 Funding capital expenditure requirements towards civil construction 5.88 3 Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company 9.37 4 General Corporate Purposes 5.64
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹20.83 Cr in the year ending 31 Mar 2023, increasing to ₹32.90 Cr by 31 Mar 2024, and further rising to ₹36.81 Cr by 31 Mar 2025. However, by 30 Sep 2025, total income decreased to ₹25.01 Cr, though this is a 6-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit after tax was ₹0.82 Cr in the year ending 31 Mar 2023, increasing to ₹2.31 Cr by 31 Mar 2024, and further rising to ₹4.48 Cr by 31 Mar 2025. By 30 Sep 2025, profit after tax decreased to ₹3.75 Cr, though this is a 6-month figure, not a full year, so isn't directly comparable.
Valuation
Priced at roughly 17.24 times trailing earnings, versus peers trading at P/E ratios ranging from 14.43 to 20.49.
Grey Market Premium, Explained
The grey market refers to the unofficial market where shares of a company are bought and sold before they are officially listed on the stock exchange. The Grey Market Premium (GMP) indicates the expected listing price of the shares compared to the issue price. A positive GMP suggests that the shares may list at a higher price than the issue price, while a negative GMP indicates the opposite.
Subscription Demand
As of December 22, 2025, the IPO was subscribed 0.57 times overall, with the retail category (RII) subscribed 0.83 times and the non-institutional investors (NII) category subscribed 0.31 times.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's fundamentals and market conditions.
Who May Want to Wait
Investors with a low risk tolerance or those looking for guaranteed short-term returns may want to avoid this IPO, as the stock market can be unpredictable, especially on listing day.
IPO Timeline, Explained
The IPO process includes several key dates: the issue opens on December 18, 2025, and closes on December 22, 2025. Allotment of shares is expected on December 23, 2025, with the listing on the stock exchange scheduled for December 26, 2025.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when shares are listed on the stock exchange at a price higher than the issue price. However, these gains are not guaranteed, and various factors such as market conditions, investor sentiment, and company performance can influence the listing price.
This evaluation is generated from Phytochem Remedies's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
When does Phytochem Remedies IPO open and close?
Phytochem Remedies IPO opens on 18 December 2025 and closes on 22 December 2025.
When does Phytochem Remedies IPO list on the stock exchange?
Phytochem Remedies IPO listed on 26 December 2025.
What is the lot size for Phytochem Remedies IPO?
The lot size for Phytochem Remedies IPO is 1200 shares, requiring a minimum investment of ₹235,200 (2 lots).
What is the issue price of the Phytochem Remedies IPO?
The issue price is ₹98.0.
What is the lot size for the Phytochem Remedies IPO?
The lot size is 1200 shares.
What is the minimum investment required for the Phytochem Remedies IPO?
The minimum investment required is ₹235,200.
When does the Phytochem Remedies IPO open and close?
The IPO opens on December 18, 2025, and closes on December 22, 2025.
What does GMP mean in the context of IPOs?
GMP stands for Grey Market Premium, which indicates the expected listing price of the shares compared to the issue price.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
18 Dec 2025
Close
22 Dec 2025
Allotment
23 Dec 2025
Listing
26 Dec 2025
Similar IPOs in Other Consumer Services
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Phytochem Remedies?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.